Topic

Pennsylvania

A collection of 499 issues

How to Get Rezlidhia (olutasidenib) Covered by Aetna (CVS Health) in Pennsylvania: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Rezlidhia (olutasidenib) Covered by Aetna (CVS Health) in Pennsylvania Fastest path to approval: Submit prior authorization through CVS Caremark or Aetna provider portal with IDH1 mutation test results, AML diagnosis confirmation, and documented failure of preferred alternatives. If denied, request peer-to-peer review within 180 days, then file
6 min read

How to Get Enhertu (fam-trastuzumab deruxtecan-nxki) Covered by Blue Cross Blue Shield in Pennsylvania: Appeals Guide and Forms

Answer Box: Getting Enhertu Covered by Blue Cross Blue Shield in Pennsylvania Enhertu (fam-trastuzumab deruxtecan-nxki) requires prior authorization from all Blue Cross Blue Shield plans in Pennsylvania. Submit HER2 testing results, prior therapy failure documentation, and medical necessity letter via your BCBS provider portal or PA fax line. If denied,
5 min read

Work With Your Doctor to Get Rystiggo (rozanolixizumab-noli) Covered by Cigna in Pennsylvania: Complete Appeals Guide

Answer Box: Getting Rystiggo (rozanolixizumab-noli) Covered by Cigna in Pennsylvania Cigna requires prior authorization for Rystiggo (rozanolixizumab-noli) through Express Scripts. To get approval in Pennsylvania: (1) Have your neurologist submit a medical necessity letter documenting generalized myasthenia gravis with AChR or MuSK antibodies and prior therapy failures via CoverMyMeds or
6 min read

How to Get Humate-P Covered by UnitedHealthcare in Pennsylvania: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Humate-P Covered by UnitedHealthcare in Pennsylvania UnitedHealthcare requires prior authorization for Humate-P (antihemophilic factor/vWF complex) in Pennsylvania, with step therapy requiring documentation of desmopressin (DDAVP) trial failure or contraindications. Submit PA via UHC Provider Portal with complete VWD subtype documentation, dosing calculations, and wastage justification. If
6 min read

How to Get Emgality (galcanezumab-gnlm) Covered by UnitedHealthcare in Pennsylvania: Complete Prior Authorization Guide 2025

Answer Box: Getting Emgality Covered by UnitedHealthcare in Pennsylvania Emgality (galcanezumab-gnlm) requires prior authorization from UnitedHealthcare in Pennsylvania. To get approved, you need documented failure of at least two migraine preventives (like topiramate and propranolol) and ≥4 migraine days per month. If denied, Pennsylvania's external review program overturns
7 min read

How Long Does It Take to Get Opfolda (Miglustat) Approved by UnitedHealthcare in Pennsylvania? Complete Timeline & Appeals Guide

Answer Box: Getting Opfolda (Miglustat) Covered by UnitedHealthcare in Pennsylvania Typical timeline: 7-14 business days for standard prior authorization through OptumRx. Fastest path: Submit both Opfolda and Pombiliti PA requests simultaneously via the UnitedHealthcare Provider Portal with complete documentation of late-onset Pompe disease diagnosis, failed enzyme replacement therapy (ERT), and
6 min read

How to Get Palynziq (pegvaliase-pqpz) Covered by Cigna in Pennsylvania: Complete Appeals Guide with Forms and Timelines

Quick Answer: Getting Palynziq (pegvaliase-pqpz) Covered by Cigna in Pennsylvania Cigna requires prior authorization for Palynziq with strict criteria: confirmed PKU, age ≥18, blood phenylalanine ≥600 µmol/L despite optimized diet, REMS enrollment, and epinephrine prescription. First step: Have your metabolic specialist submit a comprehensive PA request with baseline Phe
5 min read

The Requirements Checklist to Get Strimvelis (Autologous CD34+ ADA-SCID Gene Therapy) Covered by Blue Cross Blue Shield in Pennsylvania

Answer Box: Fast Track to Approval Getting Strimvelis (autologous CD34+ ADA-SCID gene therapy) covered by Blue Cross Blue Shield in Pennsylvania requires prior authorization via medical exception due to non-FDA approval and international treatment location (SR-TIGET, Milan). Success depends on: (1) confirmed ADA-SCID diagnosis with biallelic ADA mutations and enzyme
6 min read

Resources to Get Arikayce (Amikacin Liposome Inhalation) Approved with Cigna in Pennsylvania: Complete Forms, Portals & Contact Guide

Answer Box: Getting Arikayce Covered by Cigna in Pennsylvania Fastest path to approval: Your pulmonologist must submit a prior authorization request through Cigna's provider portal or call 1-800-882-4462, documenting refractory MAC lung disease with ≥6 months of failed multi-drug therapy and positive cultures. First step today: Contact your
5 min read